Philippe Ledru serves as Executive at Aptose Biosciences Inc., where they oversee executive responsibilities. Since joining the company, Philippe Ledru has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 19, 2023 involved receiving (via award) 100,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 19, 2023 | APTO | $0 | Award | 100,000 | $N/A | Discretionary |
Philippe Ledru currently holds 100,500 shares of Aptose Biosciences Inc. (APTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philippe Ledru has been a net neutral trader of APTO stock. They have purchased $0 and sold $0 worth of shares.
Philippe Ledru's most recent insider trade was on Jan 19, 2023, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted